New Insights into the Role of Ubiquitin Networks in the Regulation of Antiapoptosis Pathways

International Review of Cell and Molecular Biology

Volumn 318, Issue , 2015, Pages 121-158

  Asaoka, Tomoko ^a   Ikeda, Fumiyo ^a  

^a INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

Author keywords

Apoptosis signaling; Deubiquitinase; Tumor necrosis factor; Ubiquitin chain; Ubiquitin E3 ligase

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; PROTEASOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL; APOPTOSIS; CELL SURVIVAL; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; APOPTOSIS; CELL SURVIVAL; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84940467117     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2015.05.003     Document Type: Article

References (211)

1. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326.
2. Amerik A., Swaminathan S., Krantz B.A., Wilkinson K.D., Hochstrasser M. In vivo disassembly of free polyubiquitin chains by yeast Ubp14 modulates rates of protein degradation by the proteasome. EMBO J. 1997, 16:4826-4838.
3. Antonsson B., Martinou J.C. The Bcl-2 protein family. Exp. Cell Res. 2000, 256:50-57.
4. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
5. Avvakumov G.V., Walker J.R., Xue S., Finerty P.J., Mackenzie F., Newman E.M., Dhe-Paganon S. Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8). J. Biol. Chem. 2006, 281:38061-38070.
6. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., Brunskill E.W., Sayen M.R., Gottlieb R.A., Dorn G.W., Robbins J., Molkentin J.D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434:658-662.
7. Baker R.T., Board P.G. The human ubiquitin gene family: structure of a gene and pseudogenes from the Ub B subfamily. Nucleic Acids Res. 1987, 15:443-463.
8. Baker R.T., Board P.G. The human ubiquitin-52 amino acid fusion protein gene shares several structural features with mammalian ribosomal protein genes. Nucleic Acids Res. 1991, 19:1035-1040.
9. Bao Q., Shi Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ. 2007, 14:56-65.
10. Basso E., Fante L., Fowlkes J., Petronilli V., Forte M.A., Bernardi P. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J. Biol. Chem. 2005, 280:18558-18561.
11. Beal R., Deveraux Q., Xia G., Rechsteiner M., Pickart C. Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:861-866.
12. Beal R.E., Toscano-Cantaffa D., Young P., Rechsteiner M., Pickart C.M. The hydrophobic effect contributes to polyubiquitin chain recognition. Biochemistry 1998, 37:2925-2934.
13. Bellail A.C., Olson J.J., Yang X., Chen Z.J., Hao C. A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma. Cancer Discov. 2012, 2:140-155.
14. Bertrand M.J., Milutinovic S., Dickson K.M., Ho W.C., Boudreault A., Durkin J., Gillard J.W., Jaquith J.B., Morris S.J., Barker P.A. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 2008, 30:689-700.
15. Blankenship J.W., Varfolomeev E., Goncharov T., Fedorova A.V., Kirkpatrick D.S., Izrael-Tomasevic A., Phu L., Arnott D., Aghajan M., Zobel K., Bazan J.F., Fairbrother W.J., Deshayes K., Vucic D. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1). Biochem. J. 2009, 417:149-160.
16. Boisvert F.M., Chenard C.A., Richard S. Protein interfaces in signaling regulated by arginine methylation. Sci. STKE 2005, 2005:re2.
17. Broemer M., Meier P. Ubiquitin-mediated regulation of apoptosis. Trends Cell Biol. 2009, 19:130-140.
18. Brummelkamp T.R., Nijman S.M., Dirac A.M., Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003, 424:797-801.
19. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 1999, 15:269-290.
20. Chang L., Kamata H., Solinas G., Luo J.L., Maeda S., Venuprasad K., Liu Y.C., Karin M. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006, 124:601-613.
21. Chen Z., Hagler J., Palombella V.J., Melandri F., Scherer D., Ballard D., Maniatis T. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 1995, 9:1586-1597.
22. Chernorudskiy A.L., Gainullin M.R. Ubiquitin system: direct effects join the signaling. Sci. Signal. 2013, 6:pe22.
23. Chi W., Li F., Chen H., Wang Y., Zhu Y., Yang X., Zhu J., Wu F., Ouyang H., Ge J., Weinreb R.N., Zhang K., Zhuo Y. Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1beta production in acute glaucoma. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:11181-11186.
24. Choi Y.E., Butterworth M., Malladi S., Duckett C.S., Cohen G.M., Bratton S.B. The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing. J. Biol. Chem. 2009, 284:12772-12782.
25. Ciechanover A., Finley D., Varshavsky A. The ubiquitin-mediated proteolytic pathway and mechanisms of energy-dependent intracellular protein degradation. J. Cell. Biochem. 1984, 24:27-53.
26. Ciehanover A., Hod Y., Hershko A. A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem. Biophys. Res. Commun. 1978, 81:1100-1105.
27. Clague M.J., Barsukov I., Coulson J.M., Liu H., Rigden D.J., Urbe S. Deubiquitylases from genes to organism. Physiol. Rev. 2013, 93:1289-1315.
28. Cohen P. The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 1989, 58:453-508.
29. Compagno M., Lim W.K., Grunn A., Nandula S.V., Brahmachary M., Shen Q., Bertoni F., Ponzoni M., Scandurra M., Califano A., Bhagat G., Chadburn A., Dalla-Favera R., Pasqualucci L. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 2009, 459:717-721.
30. Cummins J.M., Rago C., Kohli M., Kinzler K.W., Lengauer C., Vogelstein B. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 2004, 428. 1 p. following 486.
31. Datta A.B., Hura G.L., Wolberger C. The structure and conformation of Lys63-linked tetraubiquitin. J. Mol. Biol. 2009, 392:1117-1124.
32. Dayal S., Sparks A., Jacob J., Allende-Vega N., Lane D.P., Saville M.K. Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53. J. Biol. Chem. 2009, 284:5030-5041.
33. Dickens L.S., Powley I.R., Hughes M.A., MacFarlane M. The 'complexities' of life and death: death receptor signalling platforms. Exp. Cell. Res. 2012, 318:1269-1277.
34. Duda D.M., Olszewski J.L., Schuermann J.P., Kurinov I., Miller D.J., Nourse A., Alpi A.F., Schulman B.A. Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism. Structure 2013, 21:1030-1041.
35. Dynek J.N., Goncharov T., Dueber E.C., Fedorova A.V., Izrael-Tomasevic A., Phu L., Helgason E., Fairbrother W.J., Deshayes K., Kirkpatrick D.S., Vucic D. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 2010, 29:4198-4209.
36. Eddins M.J., Varadan R., Fushman D., Pickart C.M., Wolberger C. Crystal structure and solution NMR studies of Lys48-linked tetraubiquitin at neutral pH. J. Mol. Biol. 2007, 367:204-211.
37. Elliott P.R., Nielsen S.V., Marco-Casanova P., Fiil B.K., Keusekotten K., Mailand N., Freund S.M., Gyrd-Hansen M., Komander D. Molecular basis and regulation of OTULIN-LUBAC interaction. Mol. Cell 2014, 54:335-348.
38. Emmerich C.H., Ordureau A., Strickson S., Arthur J.S., Pedrioli P.G., Komander D., Cohen P. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:15247-15252.
39. Ermolaeva M.A., Michallet M.C., Papadopoulou N., Utermohlen O., Kranidioti K., Kollias G., Tschopp J., Pasparakis M. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat. Immunol. 2008, 9:1037-1046.
40. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 1992, 148:2207-2216.
41. Feoktistova M., Leverkus M. Programmed necrosis and necroptosis signalling. FEBS J. 2015, 282:19-31.
42. Finley D., Bartel B., Varshavsky A. The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis. Nature 1989, 338:394-401.
43. Finley D., Chau V. Ubiquitination. Annu. Rev. Cell Biol. 1991, 7:25-69.
44. Fornace A.J., Alamo I., Hollander M.C., Lamoreaux E. Ubiquitin mRNA is a major stress-induced transcript in mammalian cells. Nucleic Acids Res. 1989, 17:1215-1230.
45. Fuentes-Prior P., Salvesen G.S. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 2004, 384:201-232.
46. Fukazawa T., Fujiwara T., Uno F., Teraishi F., Kadowaki Y., Itoshima T., Takata Y., Kagawa S., Roth J.A., Tschopp J., Tanaka N. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene 2001, 20:5225-5231.
47. Galluzzi L., Maiuri M.C., Vitale I., Zischka H., Castedo M., Zitvogel L., Kroemer G. Cell death modalities: classification and pathophysiological implications. Cell Death Differ. 2007, 14:1237-1243.
48. Galluzzi L., Zamzami N., de La Motte Rouge T., Lemaire C., Brenner C., Kroemer G. Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis 2007, 12:803-813.
49. Gerlach B., Cordier S.M., Schmukle A.C., Emmerich C.H., Rieser E., Haas T.L., Webb A.I., Rickard J.A., Anderton H., Wong W.W., Nachbur U., Gangoda L., Warnken U., Purcell A.W., Silke J., Walczak H. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011, 471:591-596.
50. Geserick P., Hupe M., Moulin M., Wong W.W., Feoktistova M., Kellert B., Gollnick H., Silke J., Leverkus M. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J. Cell Biol. 2009, 187:1037-1054.
51. Geyer R.K., Yu Z.K., Maki C.G. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2000, 2:569-573.
52. Goncharov T., Niessen K., de Almagro M.C., Izrael-Tomasevic A., Fedorova A.V., Varfolomeev E., Arnott D., Deshayes K., Kirkpatrick D.S., Vucic D. OTUB1 modulates c-IAP1 stability to regulate signalling pathways. EMBO J. 2013, 32:1103-1114.
53. Gonzalvez F., Lawrence D., Yang B., Yee S., Pitti R., Marsters S., Pham V.C., Stephan J.P., Lill J., Ashkenazi A. TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Mol. Cell 2012, 48:888-899.
54. Green D.R., Chipuk J.E. Apoptosis: Stabbed in the BAX. Nature 2008, 455:1047-1049.
55. Gyrd-Hansen D., Kristiansen I.S. Preferences for 'life-saving' programmes: small for all or gambling for the prize?. Health Econ. 2008, 17:709-720.
56. Haas A.L., Bright P.M. The dynamics of ubiquitin pools within cultured human lung fibroblasts. J. Biol. Chem. 1987, 262:345-351.
57. Haas A.L., Bright P.M. The resolution and characterization of putative ubiquitin carrier protein isozymes from rabbit reticulocytes. J. Biol. Chem. 1988, 263:13258-13267.
58. Haas T.L., Emmerich C.H., Gerlach B., Schmukle A.C., Cordier S.M., Rieser E., Feltham R., Vince J., Warnken U., Wenger T., Koschny R., Komander D., Silke J., Walczak H. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 2009, 36:831-844.
59. Haglund K., Dikic I. Ubiquitylation and cell signaling. EMBO J. 2005, 24:3353-3359.
60. Harhaj E.W., Dixit V.M. Regulation of NF-κB by deubiquitinases. Immunol Rev. 2012, 246:107-124.
61. Harper N., Hughes M., MacFarlane M., Cohen G.M. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J. Biol. Chem. 2003, 278:25534-25541.
62. Haslett C. Introduction-the paradox of inflammation. Semin. Cell Biol. 1995, 6:315-316.
63. Haupt S., Berger M., Goldberg Z., Haupt Y. Apoptosis - the p53 network. J. Cell Sci. 2003, 116:4077-4085.
64. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
65. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
66. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
67. Hershko A. Ubiquitin: roles in protein modification and breakdown. Cell 1983, 34:11-12.
68. Hershko A., Ciechanover A. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 1992, 61:761-807.
69. Hicke L., Schubert H.L., Hill C.P. Ubiquitin-binding domains. Nat. Rev. Mol. Cell Biol. 2005, 6:610-621.
70. Ho S.R., Mahanic C.S., Lee Y.J., Lin W.C. RNF144A, an E3 ubiquitin ligase for DNA-PKcs, promotes apoptosis during DNA damage. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:E2646-E2655.
71. Hoeller D., Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 2009, 458:438-444.
72. Hofmann K., Bucher P., Tschopp J. The CARD domain: a new apoptotic signalling motif. Trends Biochem. Sci. 1997, 22:155-156.
73. Hoppe T. Multiubiquitylation by E4 enzymes: 'one size' doesn't fit all. Trends Biochem. Sci. 2005, 30:183-187.
74. Hou X., Wang L., Zhang L., Pan X., Zhao W. Ubiquitin-specific protease 4 promotes TNF-alpha-induced apoptosis by deubiquitination of RIP1 in head and neck squamous cell carcinoma. FEBS Lett. 2013, 587:311-316.
75. Hu M., Li P., Li M., Li W., Yao T., Wu J.W., Gu W., Cohen R.E., Shi Y. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 2002, 111:1041-1054.
76. Hu M., Li P., Song L., Jeffrey P.D., Chenova T.A., Wilkinson K.D., Cohen R.E., Shi Y. Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J. 2005, 24:3747-3756.
77. Hunt L.T., Dayhoff M.O. Amino-terminal sequence identity of ubiquitin and the nonhistone component of nuclear protein A24. Biochem. Biophys. Res. Commun. 1977, 74:650-655.
78. Husnjak K., Dikic I. Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu. Rev. Biochem. 2012, 81:291-322.
79. Ikeda F., Deribe Y.L., Skanland S.S., Stieglitz B., Grabbe C., Franz-Wachtel M., van Wijk S.J., Goswami P., Nagy V., Terzic J., Tokunaga F., Androulidaki A., Nakagawa T., Pasparakis M., Iwai K., Sundberg J.P., Schaefer L., Rittinger K., Macek B., Dikic I. SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature 2011, 471:637-641.
80. Ikeda F., Dikic I. Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep. 2008, 9:536-542.
81. Jin Z., Li Y., Pitti R., Lawrence D., Pham V.C., Lill J.R., Ashkenazi A. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 2009, 137:721-735.
82. Jono H., Lim J.H., Chen L.F., Xu H., Trompouki E., Pan Z.K., Mosialos G., Li J.D. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J. Biol. Chem. 2004, 279:36171-36174.
83. Kaczmarek A., Vandenabeele P., Krysko D.V. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013, 38:209-223.
84. Kaiser P., Tagwerker C. Is this protein ubiquitinated?. Methods Enzymol. 2005, 399:243-248.
85. Kanarek N., London N., Schueler-Furman O., Ben-Neriah Y. Ubiquitination and degradation of the inhibitors of NF-kappaB. Cold Spring Harb. Perspect. Biol. 2010, 2:a000166.
86. Kanayama A., Seth R.B., Sun L., Ea C.K., Hong M., Shaito A., Chiu Y.H., Deng L., Chen Z.J. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol. Cell 2004, 15:535-548.
87. Kang T.B., Yang S.H., Toth B., Kovalenko A., Wallach D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 2013, 38:27-40.
88. Kato M., Sanada M., Kato I., Sato Y., Takita J., Takeuchi K., Niwa A., Chen Y., Nakazaki K., Nomoto J., Asakura Y., Muto S., Tamura A., Iio M., Akatsuka Y., Hayashi Y., Mori H., Igarashi T., Kurokawa M., Chiba S., Mori S., Ishikawa Y., Okamoto K., Tobinai K., Nakagama H., Nakahata T., Yoshino T., Kobayashi Y., Ogawa S. Frequent inactivation of A20 in B-cell lymphomas. Nature 2009, 459:712-716.
89. Kaunisto A., Kochin V., Asaoka T., Mikhailov A., Poukkula M., Meinander A., Eriksson J.E. PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability. Cell Death Differ. 2009, 16:1215-1226.
90. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26:239-257.
91. Kim J.B., Kim S.Y., Kim B.M., Lee H., Kim I., Yun J., Jo Y., Oh T., Jo Y., Chae H.D., Shin D.Y. Identification of a novel anti-apoptotic E3 ubiquitin ligase that ubiquitinates antagonists of inhibitor of apoptosis proteins SMAC, HtrA2, and ARTS. J. Biol. Chem. 2013, 288:12014-12021.
92. Kirisako T., Kamei K., Murata S., Kato M., Fukumoto H., Kanie M., Sano S., Tokunaga F., Tanaka K., Iwai K. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 2006, 25:4877-4887.
93. Kirkin V., Dikic I. Role of ubiquitin- and Ubl-binding proteins in cell signaling. Curr. Opin. Cell Biol. 2007, 19:199-205.
94. Kirkpatrick D.S., Hathaway N.A., Hanna J., Elsasser S., Rush J., Finley D., King R.W., Gygi S.P. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nat. Cell Biol. 2006, 8:700-710.
95. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997, 275:1132-1136.
96. Koegl M., Hoppe T., Schlenker S., Ulrich H.D., Mayer T.U., Jentsch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 1999, 96:635-644.
97. Komander D. The emerging complexity of protein ubiquitination. Biochem. Soc. Trans. 2009, 37:937-953.
98. Komander D., Barford D. Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem. J. 2008, 409:77-85.
99. Komander D., Clague M.J., Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 2009, 10:550-563.
100. Komander D., Rape M. The ubiquitin code. Annu. Rev. Biochem. 2012, 81:203-229.
101. van de Kooij B., Verbrugge I., de Vries E., Gijsen M., Montserrat V., Maas C., Neefjes J., Borst J. Ubiquitination by the membrane-associated RING-CH-8 (MARCH-8) ligase controls steady-state cell surface expression of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor 1. J. Biol. Chem. 2013, 288:6617-6628.
102. Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D., Courtois G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 2003, 424:801-805.
103. Koyano F., Okatsu K., Kosako H., Tamura Y., Go E., Kimura M., Kimura Y., Tsuchiya H., Yoshihara H., Hirokawa T., Endo T., Fon E.A., Trempe J.F., Saeki Y., Tanaka K., Matsuda N. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 2014, 510:162-166.
104. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87:99-163.
105. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., El-Deiry W.S., Golstein P., Green D.R., Hengartner M., Knight R.A., Kumar S., Lipton S.A., Malorni W., Nunez G., Peter M.E., Tschopp J., Yuan J., Piacentini M., Zhivotovsky B., Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16:3-11. Nomenclature Committee on Cell, D.
106. Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature 1997, 387:299-303.
107. Kumari S., Redouane Y., Lopez-Mosqueda J., Shiraishi R., Romanowska M., Lutzmayer S., Kuiper J., Martinez C., Dikic I., Pasparakis M., Ikeda F. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. eLife 2014, 3.
108. Kuwana T., Smith J.J., Muzio M., Dixit V., Newmeyer D.D., Kornbluth S. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J. Biol. Chem. 1998, 273:16589-16594.
109. Laherty C.D., Hu H.M., Opipari A.W., Wang F., Dixit V.M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J. Biol. Chem. 1992, 267:24157-24160.
110. Lam Y.A., Xu W., DeMartino G.N., Cohen R.E. Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome. Nature 1997, 385:737-740.
111. Laptenko O., Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ. 2006, 13:951-961.
112. Lauber K., Blumenthal S.G., Waibel M., Wesselborg S. Clearance of apoptotic cells: getting rid of the corpses. Mol. Cell 2004, 14:277-287.
113. Lavrik I.N., Krammer P.H. Regulation of CD95/Fas signaling at the DISC. Cell Death Differ. 2012, 19:36-41.
114. Lee E.G., Boone D.L., Chai S., Libby S.L., Chien M., Lodolce J.P., Ma A. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 2000, 289:2350-2354.
115. Lee E.W., Kim J.H., Ahn Y.H., Seo J., Ko A., Jeong M., Kim S.J., Ro J.Y., Park K.M., Lee H.W., Park E.J., Chun K.H., Song J. Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Nat. Commun. 2012, 3:978.
116. Li M., Beg A.A. Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J. Virol. 2000, 74:7470-7477.
117. Li M., Brooks C.L., Kon N., Gu W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 2004, 13:879-886.
118. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489.
119. Lin S.C., Chung J.Y., Lamothe B., Rajashankar K., Lu M., Lo Y.C., Lam A.Y., Darnay B.G., Wu H. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20. J. Mol. Biol. 2008, 376:526-540.
120. Lo Y.C., Lin S.C., Rospigliosi C.C., Conze D.B., Wu C.J., Ashwell J.D., Eliezer D., Wu H. Structural basis for recognition of diubiquitins by NEMO. Mol. Cell 2009, 33:602-615.
121. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501.
122. Luise C., Capra M., Donzelli M., Mazzarol G., Jodice M.G., Nuciforo P., Viale G., Di Fiore P.P., Confalonieri S. An atlas of altered expression of deubiquitinating enzymes in human cancer. PLoS One 2011, 6:e15891.
123. Lund P.K., Moats-Staats B.M., Simmons J.G., Hoyt E., D'Ercole A.J., Martin F., Van Wyk J.J. Nucleotide sequence analysis of a cDNA encoding human ubiquitin reveals that ubiquitin is synthesized as a precursor. J. Biol. Chem. 1985, 260:7609-7613.
124. Martin D.A., Combadiere B., Hornung F., Jiang D., McFarland H., Siegel R., Trageser C., Wang J., Zheng L., Lenardo M.J. Molecular genetic studies in lymphocyte apoptosis and human autoimmunity. Novartis Found. Symp. 1998, 215:73-82. discussion 82-91.
125. McDonald E.R., El-Deiry W.S. Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:6170-6175.
126. Messick T.E., Russell N.S., Iwata A.J., Sarachan K.L., Shiekhattar R., Shanks J.R., Reyes-Turcu F.E., Wilkinson K.D., Marmorstein R. Structural basis for ubiquitin recognition by the Otu1 ovarian tumor domain protein. J. Biol. Chem. 2008, 283:11038-11049.
127. Meyer H.J., Rape M. Enhanced protein degradation by branched ubiquitin chains. Cell 2014, 157:910-921.
128. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
129. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299.
130. Moraes T.F., Edwards R.A., McKenna S., Pastushok L., Xiao W., Glover J.N., Ellison M.J. Crystal structure of the human ubiquitin conjugating enzyme complex, hMms2-hUbc13. Nat. Struct. Biol. 2001, 8:669-673.
131. Moulin M., Anderton H., Voss A.K., Thomas T., Wong W.W., Bankovacki A., Feltham R., Chau D., Cook W.D., Silke J., Vaux D.L. IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J. 2012, 31:1679-1691.
132. Murray R.Z., Jolly L.A., Wood S.A. The FAM deubiquitylating enzyme localizes to multiple points of protein trafficking in epithelia, where it associates with E-cadherin and beta-catenin. Mol. Biol. Cell 2004, 15:1591-1599.
133. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., Dixit V.M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996, 85:817-827.
134. Nagy V., Dikic I. Ubiquitin ligase complexes: from substrate selectivity to conjugational specificity. Biol. Chem. 2010, 391:163-169.
135. Neutzner A., Li S., Xu S., Karbowski M. The ubiquitin/proteasome system-dependent control of mitochondrial steps in apoptosis. Semin. Cell Dev. Biol. 2012, 23:499-508.
136. Newton K., Matsumoto M.L., Wertz I.E., Kirkpatrick D.S., Lill J.R., Tan J., Dugger D., Gordon N., Sidhu S.S., Fellouse F.A., Komuves L., French D.M., Ferrando R.E., Lam C., Compaan D., Yu C., Bosanac I., Hymowitz S.G., Kelley R.F., Dixit V.M. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008, 134:668-678.
137. Nijman S.M., Luna-Vargas M.P., Velds A., Brummelkamp T.R., Dirac A.M., Sixma T.K., Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005, 123:773-786.
138. Oberst A., Pop C., Tremblay A.G., Blais V., Denault J.B., Salvesen G.S., Green D.R. Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. J. Biol. Chem. 2010, 285:16632-16642.
139. Ofengeim D., Yuan J. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat. Rev. Mol. Cell Biol. 2013, 14:727-736.
140. Oh C., Park S., Lee E.K., Yoo Y.J. Downregulation of ubiquitin level via knockdown of polyubiquitin gene Ubb as potential cancer therapeutic intervention. Sci. Rep. 2013, 3:2623.
141. Olsen S.K., Lima C.D. Structure of a ubiquitin E1-E2 complex: insights to E1-E2 thioester transfer. Mol. Cell 2013, 49:884-896.
142. Ozkaynak E., Finley D., Varshavsky A. The yeast ubiquitin gene: head-to-tail repeats encoding a polyubiquitin precursor protein. Nature 1984, 312:663-666.
143. Park S.M., Yoon J.B., Lee T.H. Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro. FEBS Lett. 2004, 566:151-156.
144. Parrish A.B., Freel C.D., Kornbluth S. Cellular mechanisms controlling caspase activation and function. Cold Spring Harb. Perspect. Biol. 2013, 5.
145. Peltzer N., Rieser E., Taraborrelli L., Draber P., Darding M., Pernaute B., Shimizu Y., Sarr A., Draberova H., Montinaro A., Martinez-Barbera J.P., Silke J., Rodriguez T.A., Walczak H. HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep. 2014, 9:153-165.
146. Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 2007, 8:49-62.
147. Petroski M.D., Deshaies R.J. Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34. Cell 2005, 123:1107-1120.
148. Pickart C.M., Fushman D. Polyubiquitin chains: polymeric protein signals. Curr. Opin. Chem. Biol. 2004, 8:610-616.
149. Pickart C.M., Rose I.A. Functional heterogeneity of ubiquitin carrier proteins. J. Biol. Chem. 1985, 260:1573-1581.
150. Platt N., da Silva R.P., Gordon S. Class A scavenger receptors and the phagocytosis of apoptotic cells. Biochem. Soc. Trans. 1998, 26:639-644.
151. Pobezinskaya Y.L., Kim Y.S., Choksi S., Morgan M.J., Li T., Liu C., Liu Z. The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors. Nat. Immunol. 2008, 9:1047-1054.
152. Poukkula M., Kaunisto A., Hietakangas V., Denessiouk K., Katajamaki T., Johnson M.S., Sistonen L., Eriksson J.E. Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail. J. Biol. Chem. 2005, 280:27345-27355.
153. Rahighi S., Ikeda F., Kawasaki M., Akutsu M., Suzuki N., Kato R., Kensche T., Uejima T., Bloor S., Komander D., Randow F., Wakatsuki S., Dikic I. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 2009, 136:1098-1109.
154. van Raam B.J., Salvesen G.S. Proliferative versus apoptotic functions of caspase-8 Hetero or homo: the caspase-8 dimer controls cell fate. Biochim. Biophys. Acta 2012, 1824:113-122.
155. Redman K.L., Rechsteiner M. Identification of the long ubiquitin extension as ribosomal protein S27a. Nature 1989, 338:438-440.
156. Reed J.C. Apoptosis-based therapies. Nat. Rev. Drug Discov. 2002, 1:111-121.
157. Reed J.C., Doctor K.S., Godzik A. The domains of apoptosis: a genomics perspective. Sci. STKE 2004, 2004:re9.
158. Reiley W., Zhang M., Wu X., Granger E., Sun S.C. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation. Mol. Cell. Biol. 2005, 25:3886-3895.
159. Reyes-Turcu F.E., Horton J.R., Mullally J.E., Heroux A., Cheng X., Wilkinson K.D. The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin. Cell 2006, 124:1197-1208.
160. Rickard J.A., Anderton H., Etemadi N., Nachbur U., Darding M., Peltzer N., Lalaoui N., Lawlor K.E., Vanyai H., Hall C., Bankovacki A., Gangoda L., Wong W.W., Corbin J., Huang C., Mocarski E.S., Murphy J.M., Alexander W.S., Voss A.K., Vaux D.L., Kaiser W.J., Walczak H., Silke J. TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. eLife 2014, 3.
161. Riedl S.J., Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 2004, 5:897-907.
162. Riley B.E., Lougheed J.C., Callaway K., Velasquez M., Brecht E., Nguyen L., Shaler T., Walker D., Yang Y., Regnstrom K., Diep L., Zhang Z., Chiou S., Bova M., Artis D.R., Yao N., Baker J., Yednock T., Johnston J.A. Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat. Commun. 2013, 4:1982.
163. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 2008, 9:402-412.
164. Ritorto M.S., Ewan R., Perez-Oliva A.B., Knebel A., Buhrlage S.J., Wightman M., Kelly S.M., Wood N.T., Virdee S., Gray N.S., Morrice N.A., Alessi D.R., Trost M. Screening of DUB activity and specificity by MALDI-TOF mass spectrometry. Nat. Commun. 2014, 5:4763.
165. Rodgers M.A., Bowman J.W., Fujita H., Orazio N., Shi M., Liang Q., Amatya R., Kelly T.J., Iwai K., Ting J., Jung J.U. The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. J. Exp. Med. 2014, 211:1333-1347.
166. Rothe M., Sarma V., Dixit V.M., Goeddel D.V. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 1995, 269:1424-1427.
167. Ryu K.Y., Maehr R., Gilchrist C.A., Long M.A., Bouley D.M., Mueller B., Ploegh H.L., Kopito R.R. The mouse polyubiquitin gene UbC is essential for fetal liver development, cell-cycle progression and stress tolerance. EMBO J. 2007, 26:2693-2706.
168. Saito K., Kigawa T., Koshiba S., Sato K., Matsuo Y., Sakamoto A., Takagi T., Shirouzu M., Yabuki T., Nunokawa E., Seki E., Matsuda T., Aoki M., Miyata Y., Hirakawa N., Inoue M., Terada T., Nagase T., Kikuno R., Nakayama M., Ohara O., Tanaka A., Yokoyama S. The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma. Structure 2004, 12:1719-1728.
169. Sato Y., Yoshikawa A., Yamagata A., Mimura H., Yamashita M., Ookata K., Nureki O., Iwai K., Komada M., Fukai S. Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains. Nature 2008, 455:358-362.
170. Schaeffer V., Akutsu M., Olma M.H., Gomes L.C., Kawasaki M., Dikic I. Binding of OTULIN to the PUB domain of HOIP controls NF-kappaB signaling. Mol. Cell 2014, 54:349-361.
171. Semple C.A., Group R.G., Members G.S.L. The comparative proteomics of ubiquitination in mouse. Genome Res. 2003, 13:1389-1394.
172. Shembade N., Parvatiyar K., Harhaj N.S., Harhaj E.W. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling. EMBO J. 2009, 28:513-522.
173. Silke J., Vucic D. IAP family of cell death and signaling regulators. Methods Enzymol. 2014, 545:35-65.
174. Skaug B., Chen J., Du F., He J., Ma A., Chen Z.J. Direct, noncatalytic mechanism of IKK inhibition by A20. Mol. Cell 2011, 44:559-571.
175. Sowa M.E., Bennett E.J., Gygi S.P., Harper J.W. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009, 138:389-403.
176. Stieglitz B., Rana R.R., Koliopoulos M.G., Morris-Davies A.C., Schaeffer V., Christodoulou E., Howell S., Brown N.R., Dikic I., Rittinger K. Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP. Nature 2013, 503:422-426.
177. Sun L., Chen Z.J. The novel functions of ubiquitination in signaling. Curr. Opin. Cell Biol. 2004, 16:119-126.
178. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 2001, 8:613-621.
179. Takiuchi T., Nakagawa T., Tamiya H., Fujita H., Sasaki Y., Saeki Y., Takeda H., Sawasaki T., Buchberger A., Kimura T., Iwai K. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN. Genes Cells 2014, 19:254-272.
180. Tenev T., Zachariou A., Wilson R., Ditzel M., Meier P. IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms. Nat. Cell Biol. 2005, 7:70-77.
181. Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., Mattmann C., Burns K., Bodmer J.L., Schroter M., Scaffidi C., Krammer P.H., Peter M.E., Tschopp J. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997, 386:517-521.
182. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science 1998, 281:1312-1316.
183. Tokunaga F., Nakagawa T., Nakahara M., Saeki Y., Taniguchi M., Sakata S., Tanaka K., Nakano H., Iwai K. SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. Nature 2011, 471:633-636.
184. Tokunaga F., Sakata S., Saeki Y., Satomi Y., Kirisako T., Kamei K., Nakagawa T., Kato M., Murata S., Yamaoka S., Yamamoto M., Akira S., Takao T., Tanaka K., Iwai K. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat. Cell Biol. 2009, 11:123-132.
185. Trompouki E., Hatzivassiliou E., Tsichritzis T., Farmer H., Ashworth A., Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 2003, 424:793-796.
186. Tsukumo S.I., Yonehara S. Requirement of cooperative functions of two repeated death effector domains in caspase-8 and in MC159 for induction and inhibition of apoptosis, respectively. Genes Cells 1999, 4:541-549.
187. Upton J.W., Kaiser W.J., Mocarski E.S. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 2010, 7:302-313.
188. Urbe S., Liu H., Hayes S.D., Heride C., Rigden D.J., Clague M.J. Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions. Mol. Biol. Cell 2012, 23:1095-1103.
189. Varadan R., Walker O., Pickart C., Fushman D. Structural properties of polyubiquitin chains in solution. J. Mol. Biol. 2002, 324:637-647.
190. Varfolomeev E., Goncharov T., Fedorova A.V., Dynek J.N., Zobel K., Deshayes K., Fairbrother W.J., Vucic D. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J. Biol. Chem. 2008, 283:24295-24299.
191. Varfolomeev E., Goncharov T., Maecker H., Zobel K., Komuves L.G., Deshayes K., Vucic D. Cellular inhibitors of apoptosis are global regulators of NF-kappaB and MAPK activation by members of the TNF family of receptors. Sci. Signal. 2012, 5:ra22.
192. Varshavsky A. The N-end rule: functions, mysteries, uses. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:12142-12149.
193. Wauer T., Swatek K.N., Wagstaff J.L., Gladkova C., Pruneda J.N., Michel M.A., Gersch M., Johnson C.M., Freund S.M., Komander D. Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. EMBO J. 2015, 34:307-325.
194. Weinlich R., Dillon C.P., Green D.R. Ripped to death. Trends Cell Biol. 2011, 21:630-637.
195. Welchman R.L., Gordon C., Mayer R.J. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat. Rev. Mol. Cell. Biol. 2005, 6:599-609.
196. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L., Ma A., Koonin E.V., Dixit V.M. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004, 430:694-699.
197. Wiborg O., Pedersen M.S., Wind A., Berglund L.E., Marcker K.A., Vuust J. The human ubiquitin multigene family: some genes contain multiple directly repeated ubiquitin coding sequences. EMBO J. 1985, 4:755-759.
198. Wilkinson K.D., Tashayev V.L., O'Connor L.B., Larsen C.N., Kasperek E., Pickart C.M. Metabolism of the polyubiquitin degradation signal: structure, mechanism, and role of isopeptidase T. Biochemistry 1995, 34:14535-14546.
199. Wilkinson K.D., Urban M.K., Haas A.L. Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. J. Biol. Chem. 1980, 255:7529-7532.
200. Won M., Park K.A., Byun H.S., Sohn K.C., Kim Y.R., Jeon J., Hong J.H., Park J., Seok J.H., Kim J.M., Yoon W.H., Jang I.S., Shen H.M., Liu Z.G., Hur G.M. Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation. Cell Death Differ. 2010, 17:1830-1841.
201. Wu X., Yen L., Irwin L., Sweeney C., Carraway K.L. Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. Mol. Cell. Biol. 2004, 24:7748-7757.
202. Wyllie A.H., Beattie G.J., Hargreaves A.D. Chromatin changes in apoptosis. Histochem. J. 1981, 13:681-692.
203. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997, 275:1129-1132.
204. Yang Q.H., Du C. Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J. Biol. Chem. 2004, 279:16963-16970.
205. Ye Y., Blaser G., Horrocks M.H., Ruedas-Rama M.J., Ibrahim S., Zhukov A.A., Orte A., Klenerman D., Jackson S.E., Komander D. Ubiquitin chain conformation regulates recognition and activity of interacting proteins. Nature 2012, 492:266-270.
206. Ye Y., Rape M. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 2009, 10:755-764.
207. Zhang H.G., Wang J., Yang X., Hsu H.C., Mountz J.D. Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 2004, 23:2009-2015.
208. Zhao L., Yue P., Khuri F.R., Sun S.Y. mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis. Cancer Res. 2013, 73:1946-1957.
209. Zhao Y., Sui X., Ren H. From procaspase-8 to caspase-8: revisiting structural functions of caspase-8. J. Cell. Physiol. 2010, 225:316-320.
210. Zhu X., Menard R., Sulea T. High incidence of ubiquitin-like domains in human ubiquitin-specific proteases. Proteins 2007, 69:1-7.
211. Zuin A., Isasa M., Crosas B. Ubiquitin signaling: extreme conservation as a source of diversity. Cells 2014, 3:690-701.